Forsight
Natural health product licensed in Canada
- Licence holder
- New Roots Herbal Inc.
- NPN or DIN-HM
- 80118766
- Status
- Active licence
- Licence date
- 18 May 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Citrate de zinc | 5 mg | 10,000 µg |
| Thiamine Source : Chlorhydrate de thiamine | 5 mg | 10,000 µg |
| Riboflavine Source : Riboflavine | 25 mg | 50,000 µg |
| Mélange de fruits Source : Vaccinium myrtillus - Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg | Not specified | Not calculated |
| Mélange de fruits Source : Vitis vinifera - Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg | Not specified | Not calculated |
| myo-inositol, Hexa-3-pyridinecarboxylate Source : Hexanicotinate d'inositol Potency : 91 % Niacin | 25 mg | Not calculated |
| myo-inositol, Hexa-3-pyridinecarboxylate Source : Hexanicotinate d'inositol Potency : 22 % Inositol | Not specified | Not calculated |
| Vitis vinifera Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 mg Potency : 80 % Oligomeric proanthocyanidins | 50 mg | Not calculated |
| Haematococcus pluvialis Source : Haematococcus pluvialis - whole Potency : 2 % Astaxanthin | 10 mg | Not calculated |
| Niacinamide Source : Niacinamide | 75 mg | Not calculated |
| Cuivre Source : Gluconate de cuivre (II) | 500 microgram | 1,000 µg |
| L-Glutathione Source : Glutathione | 25 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, Stéarate de magnésium, Dioxyde de silicium, Hypromellose, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Niacinamide helps to maintain the body's ability to metabolize nutrients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80118766
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.